Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Market Cap	$521.75M	P/E Ratio	12.39
52W High	$19.91	52W Low	$9.30
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-330.1%	52W Position	19.8%
Overall Score	50	Value Score	60
Quality Score	--	Technical Score	41

EPS Current Est	$0.92	EPS Next Est	$1.16
EPS Growth Est	+26.1%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AVNS	$11.40	+4.68%	560.84K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AVNS	$11.40	+4.7%	560.84K
3
4
5
6

AVNS

AVNS

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Avanos Medical Inc. Data in Excel

Get Avanos Medical Inc. Data in Excel